Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
Amanda has the Bank Holiday forecast for the west of the Meridian region.
Amanda Houston has the Bank Holiday weekend forecast for the east of the Meridian region.
The family and girlfriend of one of the Shoreham air disaster victims, Jacob Schilt, have spoken about their terrible loss.